Australia markets closed

Sesen Bio, Inc. (SESN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6100+0.0222 (+3.78%)
As of 11:36AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.5878
Open0.6000
Bid0.6007 x 1300
Ask0.6060 x 800
Day's range0.5851 - 0.6100
52-week range0.3650 - 0.9650
Volume334,449
Avg. volume1,071,608
Market cap123.683M
Beta (5Y monthly)0.86
PE ratio (TTM)1.85
EPS (TTM)0.3300
Earnings date27 Feb 2023 - 03 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est0.60
  • Business Wire

    Sesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Merger

    CAMBRIDGE, Mass., February 02, 2023--Sesen Bio, Inc. (NASDAQ: SESN) today filed an investor presentation highlighting its value maximizing merger with Carisma Therapeutics Inc. ("Carisma"). The presentation can be found at www.SesenBioandCarisma.com.

  • Business Wire

    Sesen Bio Receives NASDAQ Delisting Notice

    CAMBRIDGE, Mass., January 30, 2023--Sesen Bio, Inc. (Nasdaq: SESN) ("Sesen Bio" or the "Company") today announced that it has received notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") that, based upon the Company’s non-compliance with the $1.00 bid price requirement for continued listing on The Nasdaq Capital Market, the Company’s common stock is subject to delisting.

  • Business Wire

    Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests of Stockholders

    CAMBRIDGE, Mass., January 26, 2023--Sesen Bio, Inc. (Nasdaq: SESN) today issued the following statement reiterating the Company’s confidence in, and commitment to, the pending merger with Carisma Therapeutics Inc. (Carisma) in response to the release issued yesterday by Bradley Radoff and Michael Torok and their affiliates (collectively, the "Investor Group"):